A 64‐year‐old woman presented with non‐neutropenic fever and back pain one day after the first cycle of neoadjuvant chemotherapy (doxorubicin–cyclophosphamide) for locally advanced breast cancer. She had also received pegylated granulocyte colony stimulating factor (PEG‐GCSF) one day after chemotherapy to enable dose‐dense chemotherapy scheduling. She was originally treated with intravenous antibiotics and discharged home on oral amoxicillin–clavulanate, with improvement in symptoms.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Patient consent:
The patient gave written consent for publication.
Prudence Francis received an honorarium for giving a lecture at a meeting organised by Eli Lilly.